Swissmedic informs about Control Campaign against illegal Trading in Medicinal Products
Recommendation

Tuesday, 29 September 2026 14.00 - 16.00 h
GDP-compliant Transport Processes: from Risk Assessment to Practical Implementation
The flourishing illegal online trade in medicinal products poses a serious threat: it not only endangers the health of consumers but also undermines the safety and regulation of the pharmaceutical supply chain. To address this issue, Swissmedic, the Federal Office for Customs and Border Security (FOCBS) and Swiss Sport Integrity (SSI) participated in an international campaign, coordinated with Europol, to inspect over 1,000 suspicious postal shipments.
According to a Swissmedic press release dated 18 December 2024, approximately one-quarter of the inspected shipments contained illegal medicinal products or doping agents. A total of 246 packages were seized, containing products such as erectile stimulants and narcotics. Over 90% of the confiscated items originated from India, often shipped through concealed routes.
These findings highlight the critical importance of international cooperation in combating the illegal trade in medicinal products. At the same time, they draw attention to the significant health risks and the support of criminal networks associated with the purchase of such products.
The insights gained from the inspections have been shared with Europol to further intensify international efforts against the illegal trade and to strengthen the safety of the pharmaceutical supply chain.
Related GMP News
10.09.2026European GDP Association Developments May through August 2026
10.09.2026Reminder: Submit your Presentation Proposal for the GDP Forum 2027 by 30 September
10.09.2026GDP in the US: FDA Launches DSCSA Assessment for Small Dispensers and Issues Exemptions
11.08.2026GDP for APIs: APIC Publishes Updated "How to Do" Document
11.08.2026Where to Find Information on UK Wholesale Authorisations


